AMC vs CNK: Which Is the Better Buy in 2026?
Last updated November 2026
Short answer
CNK is the larger of the two ($4.75B market cap): the incumbent the market prices for continued execution (15.20x forward earnings, beta 1.04). AMC is the smaller challenger ($3.03B), actually pricier on forward earnings (40.74x): more room to run, but more to prove. The real question is which set of drivers you believe, and whether owning one (or both) leaves you over-concentrated.
AMC vs CNK: the tie-breaker metrics
Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | AMC | CNK | What it tells you |
|---|---|---|---|
| Market cap | $3.03B | $4.75B | Size. The larger name is the incumbent; the smaller has more room to grow and more to prove. |
| Forward P/E | 40.74 | 15.20 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Beta | 2.24 | 1.04 | Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through. |
| Price vs 52-week range | 87% of range | 97% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
Reading it: CNK is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.
Before you buy: how AMC and CNK affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. AMC and CNK share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined AMC and CNK exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does AMC Entertainment (AMC) do?
AMC Entertainment Holdings, Inc. (NYSE: AMC), headquartered in Leawood, Kansas, is the largest movie-theater exhibitor in the United States and the world, operating theatres across the U.S. and Europe under the AMC, Odeon, and other banners. The company makes money primarily from box-office admissions and from high-margin food and beverage sales, supplemented by on-screen advertising and premium formats. Its results are tightly tied to the strength of the theatrical film slate: a strong year of major releases lifts attendance and revenue, while a thin or delayed slate (as during the pandemic and the 2023 Hollywood strikes) can sharply reduce both. Full-year 2025 revenue was approximately $4.85 billion (up about 4% from 2024) with a net loss of about $632 million. The recovery picked up in 2026: Q1 revenue grew approximately 21% year over year to about $1.05 billion, and Q2 revenue rose about 14% to roughly $1.6 billion, with adjusted EBITDA up about 70% to roughly $321 million, free cash flow of about $190 million, and a net loss that shrank to about $11 million. Q2 EPS of $0.14 came in well above the roughly $0.03 consensus.
What does Cinemark Holdings (CNK) do?
Cinemark Holdings operates roughly 500 theaters with more than 5,500 screens across 42 US states and 13 countries in South and Central America, making it one of the largest theatrical exhibitors in the world. It earns money primarily from ticket admissions and from high-margin concessions (popcorn, drinks, snacks), supplemented by screen advertising, premium formats like XD and ScreenX, its Movie Club loyalty subscription, and theater rentals. Concessions are central to the economics because they carry far higher margins than the box office split shared with studios.
AMC vs CNK: how do they differ?
Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.
- AMC drivers: Box-Office Recovery and Film Slate; Premium Formats and Concessions.
- CNK drivers: Box-office recovery and a fuller release slate; Concessions and premium formats lift per-guest economics.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. A useful test is which set of risks you could hold through a drawdown: The dominant risk is the balance sheet: AMC carried roughly $3.85 billion in corporate borrowings (about $7.7 billion of total debt including leases) against about $778 million of cash and a stockholders' deficit near $1.45 billion as of mid-2026, so interest costs and refinancing needs weigh heavily on the equity even after the October refinancing. For CNK, cinemark's results are highly dependent on a hit-driven, unpredictable film slate, and a weak stretch of releases can quickly pressure attendance and cash flow.
AMC or CNK: which should you pick?
Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick AMC if you believe its drivers more; CNK if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the AMC and CNK guides.
AMC vs CNK: the full fundamentals
AMC. AMC's valuation is unusual because the equity story is driven heavily by debt and dilution rather than by a simple multiple of earnings. The company is still not profitable on a trailing net-income basis, so the relevant lens is enterprise value relative to a cash flow that turned positive in mid-2026 (EV/EBITDA near 16.5x), against roughly $3.85 billion of corporate borrowings and a stockholders' deficit. After an 85% rally in 2026 the shares sit just below the roughly $3.20 average analyst target with a consensus hold, and the Q3 report on October 20, 2026 (consensus about $0.10 EPS on $1.52 billion revenue) is the next test. The stock's price has also historically reflected retail sentiment and short interest tied to its meme-stock status, which can decouple it from fundamentals in both directions.
CNK. As of October 16, 2026 Cinemark traded near $39, about 22 times trailing and 14.5 times forward earnings, a lower trailing multiple than in May even after the stock's rally because earnings grew faster than the price. The average analyst target of about $40.27 sits only slightly above the current price. The sizable debt load and hit-driven revenue keep the risk profile elevated relative to steadier consumer names; figures are approximate and change with market conditions.
Headline figures (approximate, October 2026): AMC shows revenue (ttm) ~$5.23 billion; Q2 2026 ~$1.6 billion (up ~14% YoY), revenue (fy2025) ~$4.85 billion (up ~4% YoY), adjusted ebitda (q2 2026) ~$321 million (up ~70% YoY), net loss (ttm) ~$554 million; Q2 2026 net loss narrowed to ~$11 million; CNK shows revenue (ttm) ~$3.36B, q2 2026 revenue ~$1.09B (up ~15.5% YoY), net income (ttm) ~$214M (~$1.80 EPS), operating margin (ttm) ~22%.
The bottom line: AMC vs CNK
AMC and CNK are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined AMC and CNK exposure against your real portfolio. It is not an investment adviser.
Wondering how AMC or CNK fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Your questions about AMC Entertainment
Ask Walnut's AI anything about AMC and see how it fits what you own.
FAQ
What is the difference between AMC and CNK?
+
AMC Entertainment Holdings, Inc. Cinemark Holdings operates roughly 500 theaters with more than 5,500 screens across 42 US states and 13 countries in South and Central America, making it one of the largest theatrical exhibitors in the world. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is AMC or CNK the better stock?
+
Neither is universally better. CNK is the larger incumbent; AMC is the smaller challenger and looks pricier on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, AMC or CNK?
+
On forward P/E (as of November 2026), AMC trades at 40.74x and CNK at 15.20x, so CNK is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both AMC and CNK?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of AMC vs CNK?
+
AMC: The dominant risk is the balance sheet: AMC carried roughly $3.85 billion in corporate borrowings (about $7.7 billion of total debt including leases) against about $778 million of cash and a stockholders' deficit near $1.45 billion as of mid-2026, so interest costs and refinancing needs weigh heavily on the equity even after the October refinancing. Dilution is a second, recurring risk; the share count has grown by hundreds of millions over the past few years through repeated equity sales, including offerings in 2026, which mechanically reduces value per share even when the business improves. The company still lost about $554 million over the last twelve months on a GAAP basis. The secular shift toward streaming and shortened theatrical windows pressures long-run theater demand, and attendance is volatile and dependent on a film slate AMC does not control, so a weak release year can quickly reverse the recovery. After an 85% rise in 2026 the stock trades just below the roughly $3.20 average analyst target, and the meme-stock legacy means the share price can move on retail sentiment and short interest rather than fundamentals. CNK: Cinemark's results are highly dependent on a hit-driven, unpredictable film slate, and a weak stretch of releases can quickly pressure attendance and cash flow. Q1 2026 showed the seasonality: a small net loss of about $6 million in a lighter quarter, before Q2's record. After a two-thirds rise this year and a share price near its 52-week high, the stock now prices in a strong finish to 2026, and analysts expect 2027 EPS growth of only about 4%. Structural threats include streaming, shortened or collapsing theatrical windows that hurt smaller films, and the long-run question of whether moviegoing remains a durable habit. The company still carries roughly $3.0 billion of total debt against about $508 million of cash, leaving less financial flexibility than the headline profitability implies. International operations add currency and macroeconomic risk across Latin America, and cost inflation on labor and operations can compress margins.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell AMC or CNK; figures are approximate and dated (as of November 2026). Verify current data before investing.